Heli Harvala profiilikuva
Heli
Harvala
professori, biolääketieteen laitos
MD, PhD, EUPHEM Alumni, FRCPath

Ota yhteyttä

Julkaisut

Järjestä:

Coronavirus disease 2019 subphenotypes and differential treatment response to convalescent plasma in critically ill adults: secondary analyses of a randomized clinical trial (2022)

Intensive Care Medicine
Fish M, Rynne J, Jennings A, Lam C, Lamikanra AA, Ratcliff J, Cellone-Trevelin S, Timms E, Jiriha J, Tosi I, Pramanik R, Simmonds P, Seth S, Williams J, Gordon AC, Knight J, Smith DJ, Whalley J, Harrison D, Rowan K, Harvala H, Klenerman P, Estcourt L, Menon DK, Roberts D, Shankar-Hari M, REMAP-CAP Immunoglobulin Domain UK Investigators

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response (2022)

Microbiology spectrum
Otter AD, Bown A, D'Arcangelo S, Bailey D, Semper A, Hewson J, Catton M, Perumal P, Sweed A, McKee DF, Jones J, Harvala H, Lamikanra A, Zambon M, Andrews N, Whitaker H, Linley E, Mentzer AJ, Skelly D, Knight JC, Klenerman P, UKHSA Porton Euroimmun testing group, Amirthalingam G, Taylor S, Rowe C, Vipond R, Brooks T

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern (2022)

Communications medicine
Ertesvåg NU, Xiao J, Zhou F, Ljostveit S, Sandnes H, Lartey S, Sævik M, Hansen L, Madsen A, Mohn KGI, Fjelltveit E, Olofsson JS, Tan TK, Rijal P, Schimanski L, Øyen S, Brokstad KA, Dunachie S, Jämsén A, James WS, Harding AC, Harvala H, Nguyen D, Roberts D, PHE Virology group, Zambon M, Oxford collaborative group, Townsend A, Bergen COVID-19 Research Group, Langeland N, Cox RJ

Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure (2021)

Journal of Clinical Virology
López-Labrador F. Xavier, Brown Julianne R., Fischer Nicole, Harvala Heli, Van Boheemen Sander, Cinek Ondrej, Sayiner Arzu, Madsen Tina Vasehus, Auvinen Eeva, Kufner Verena, Huber Michael, Rodriguez Christophe, Jonges Marcel, Hönemann Mario, Susi Petri, Sousa Hugo, Klapper Paul E., Pérez-Cataluňa Alba, Hernandez Marta, Molenkamp Richard, van der Hoek Lia, Schuurman Rob, Couto Natacha, Leuzinger Karoline, Simmonds Peter, Beer Martin, Höper Dirk, Kamminga Sergio, Feltkamp Mariet C.W., Rodríguez-Díaz Jesús, Keyaerts Els, Nielsen Xiaohui Chen, Puchhammer-Stöckl Elisabeth, Kroes Aloys C.M., Buesa Javier, Breuer Judy, Claas Eric C.J., de Vries Jutte J.C.; on behalf of the ESCV Network on Next-Generation Sequencing
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial (2021)

JAMA: Journal of the American Medical Association
Writing Committee for the REMAP-CAP Investigators, Estcourt LJ, Turgeon AF, McQuilten ZK, McVerry BJ, Al-Beidh F, Annane D, Arabi YM, Arnold DM, Beane A, Bégin P, van Bentum-Puijk W, Berry LR, Bhimani Z, Birchall JE, Bonten MJM, Bradbury CA, Brunkhorst FM, Buxton M, Callum JL, Chassé M, Cheng AC, Cove ME, Daly J, Derde L, Detry MA, De Jong M, Evans A, Fergusson DA, Fish M, Fitzgerald M, Foley C, Goossens H, Gordon AC, Gosbell IB, Green C, Haniffa R, Harvala H, Higgins AM, Hills TE, Hoad VC, Horvat C, Huang DT, Hudson CL, Ichihara N, Laing E, Lamikanra AA, Lamontagne F, Lawler PR, Linstrum K, Litton E, Lorenzi E, MacLennan S, Marshall J, McAuley DF, McDyer JF, McGlothlin A, McGuinness S, Miflin G, Montgomery S, Mouncey PR, Murthy S, Nichol A, Parke R, Parker JC, Priddee N, Purcell DFJ, Reyes LF, Richardson P, Robitaille N, Rowan KM, Rynne J, Saito H, Santos M, Saunders CT, Serpa Neto A, Seymour CW, Silversides JA, Tinmouth AA, Triulzi DJ, Turner AM, van de Veerdonk F, Walsh TS, Wood EM, Berry S, Lewis RJ, Menon DK, McArthur C, Zarychanski R, Angus DC, Webb SA, Roberts DJ, Shankar-Hari M